Recently, CPF (circulating permeability factor)-containing plasma from FSGS patients was found to induce the accumulation of lipid droplets and perilipin-2 expression in podocytes, and perilipin-2 was proposed to be identified as a potential biomarker (124). The gene discussed is PLIN2; the disease is focal segmental glomerulosclerosis.